It was reported that on (b)(6) 2021, a 25 mm amplatzer patent foramen ovale (pfo) occluder was chosen for procedure.It was deployed normal sterile fashion and interrogated with intracardiac echocardiography (ice) and fluoroscopy.The device passed the push-pull test and was released from delivery cable.Immediately after release, the device's right atrial disc appeared to migrate into the pfo tunnel.The device was successfully removed with a 25 mm gooseneck snare through a new 10 fr amplatzer torque delivery system.The device was replaced with a 35 mm amplatzer pfo occluder, which was successfully implanted with no further issues.There was no clinically significant delay in procedure and no adverse patient effects.The patient remained hemodynamically stable throughout the procedure.No additional information was provided.
|
An event of device migration was reported.The investigation confirmed, the device met the dimensional specifications when analyzed at abbott.The device history record was reviewed, to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.The cause of the reported incident could not be conclusively determined.
|